Detalhe da pesquisa
1.
Deficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.
Circulation
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695173
2.
Hypusine Signaling Promotes Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261723
3.
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
Circ Res
; 130(9): 1466-1486, 2022 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482834
4.
Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
Circ Res
; 130(5): 760-778, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124974
5.
G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol
; 68(5): 537-550, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724371
6.
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
Thorax
; 77(3): 247-258, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226205
7.
Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 203(5): 614-627, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021405
8.
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
Circulation
; 142(15): 1464-1484, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698630
9.
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
Circ Res
; 125(4): 449-466, 2019 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154939
10.
PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol
; 40(3): 783-801, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969012
11.
Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
Int J Mol Sci
; 22(6)2021 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33805714
12.
Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach.
Int J Mol Sci
; 22(6)2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803922
13.
Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.
Am J Physiol Cell Physiol
; 318(1): C1-C28, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31483703
14.
Novel insights on the pulmonary vascular consequences of COVID-19.
Am J Physiol Lung Cell Mol Physiol
; 319(2): L277-L288, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32551862
15.
HOXA5 plays tissue-specific roles in the developing respiratory system.
Development
; 144(19): 3547-3561, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827394
16.
Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.
Circ Res
; 122(7): 1021-1032, 2018 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29599278
17.
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol
; 39(8): 1667-1681, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092016
18.
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med
; 200(7): 910-920, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042405
19.
Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking.
Am J Respir Cell Mol Biol
; 70(2): 140-143, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299796
20.
VIEWING PULMONARY HYPERTENSION THROUGH A PEDIATRIC LENS.
Eur Respir J
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575157